Equillium (EQ) Net Cash Flow (2018 - 2026)
Equillium (EQ) reported Net Cash Flow of $31.0 million for Q1 2026, up 966.61% year-over-year from $2.9 million in Q1 2025, and up 1177.1% quarter-over-quarter from -$2.9 million in Q4 2025.
Equillium (EQ) Net Cash Flow (2018 - 2026) Analysis & Trends
Equillium (EQ) has 9 years of Net Cash Flow data on file, last reported at $31.0 million in Q1 2026.
- Net Cash Flow for Q1 2026 came in at $31.0 million, up 966.61% year-over-year; the trailing twelve-month figure through Mar 2026 was $46.8 million (up 1507.18% YoY), and the FY2025 annual result was $12.1 million, up 340.59% from the prior year.
- Net Cash Flow grew to $31.0 million in Q1 2026 per EQ's latest filing, from -$2.9 million in the prior quarter.
- Over five years, Net Cash Flow peaked at $33.3 million in Q4 2022 and troughed at -$34.6 million in Q1 2023.
- A 5-year average of $639411.8 and a median of -$621000.0 in 2024 frame the typical range for Net Cash Flow.
- The sharpest annual moves came in 2025 and 2026: Net Cash Flow sank 387.76% in 2025, then jumped 966.61% in 2026.
- A 5-year view of Net Cash Flow shows it stood at $33.3 million in 2022, then sank by 133.44% to -$11.2 million in 2023, then soared by 124.84% to $2.8 million in 2024, then sank by 204.04% to -$2.9 million in 2025, then jumped by 1177.1% to $31.0 million in 2026.
- Business Quant data shows EQ's Net Cash Flow at $31.0 million in Q1 2026, -$2.9 million in Q4 2025, and $21.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 625.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 457.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 664,983.53 |
| 10 | Equillium | 293.17 Mn | 232.78 Mn | - | 31.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31.04 Mn |
| Mar 31, 2026 | 31.04 Mn |
| Dec 31, 2025 | -2.88 Mn |
| Dec 31, 2025 | -2.88 Mn |
| Sep 30, 2025 | 21.64 Mn |
| Sep 30, 2025 | 21.64 Mn |
| Jun 30, 2025 | -3.03 Mn |
| Jun 30, 2025 | -3.03 Mn |
| Mar 31, 2025 | -3.58 Mn |
| Mar 31, 2025 | -3.58 Mn |
| Dec 31, 2024 | 2.77 Mn |
| Dec 31, 2024 | 2.77 Mn |
| Sep 30, 2024 | 4.34 Mn |
| Sep 30, 2024 | 4.34 Mn |
| Jun 30, 2024 | -621,000.00 |
| Jun 30, 2024 | -621,000.00 |
| Mar 31, 2024 | -11.63 Mn |
| Mar 31, 2024 | -11.63 Mn |
| Dec 31, 2023 | -11.15 Mn |
| Dec 31, 2023 | -11.15 Mn |